Mid-treatment TARC and mid-treatment FGD-PET predict for progression free survival in classical hodgkin lymphom

OnderzoeksoutputAcademic

399 Downloads (Pure)
Originele taal-2English
ArtikelnummerT014
Pagina's (van-tot)31-31
Aantal pagina's1
TijdschriftHaematologica
Volume101
StatusPublished - 20-okt.-2016
Evenement10th International Symposium on Hodgkin Lymphoma - Germany, Cologne, Germany
Duur: 22-okt.-201625-okt.-2016

Citeer dit